Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.
The human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis. We sought to elucidate the role of common genetic variation in four of the Kallikrein genes, KLK5, KLK6, KLK12, and KLK13, in prostate canc...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2013
|
| _version_ | 1826269266190532608 |
|---|---|
| author | Lose, F Batra, J O'Mara, T Fahey, P Marquart, L Eeles, R Easton, D Al Olama, A Kote-Jarai, Z Guy, M Muir, K Lophatananon, A Rahman, A Neal, D Hamdy, F Donovan, J Chambers, S Gardiner, R Aitken, J Yaxley, J Alexander, K Clements, J Spurdle, AB Kedda, M |
| author_facet | Lose, F Batra, J O'Mara, T Fahey, P Marquart, L Eeles, R Easton, D Al Olama, A Kote-Jarai, Z Guy, M Muir, K Lophatananon, A Rahman, A Neal, D Hamdy, F Donovan, J Chambers, S Gardiner, R Aitken, J Yaxley, J Alexander, K Clements, J Spurdle, AB Kedda, M |
| author_sort | Lose, F |
| collection | OXFORD |
| description | The human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis. We sought to elucidate the role of common genetic variation in four of the Kallikrein genes, KLK5, KLK6, KLK12, and KLK13, in prostate cancer risk and tumor aggressiveness. Genotyping of all 22 tagging single nucleotide polymorphisms (tagSNPs) in the KLK5, KLK6, KLK12, and KLK13 genes was performed in approximately 1,000 prostate cancer cases and 1,300 male controls from Australia. Data from any positive results were also accessed for 1,844 cases and 1,886 controls from a previously published prostate cancer genome-wide association study set from the United Kingdom. For one SNP in KLK12, rs3865443, there was evidence for association with prostate cancer risk of similar direction and magnitude in the replication set to that seen in the Australian cohort. We conducted genotyping of a further 309 prostate cancer cases, and combined analyses revealed an increased risk of prostate cancer for carriers of the rare homozygous genotype for rs3865443 (OR 1.28, 95% CI 1.04-1.57; P = 0.018). No other tagSNPs in the KLK5, KLK6, and KLK13 genes were consistently associated with prostate cancer risk or tumor aggressiveness. Analysis of a combined sample of 3,153 cases and 3,199 controls revealed the KLK12 tagSNP rs3865443 to be marginally statistically significantly associated with risk of prostate cancer. Considering the total number of SNPs investigated in this study, this finding should be interpreted cautiously and requires additional validation from very large datasets such as those of the Prostate Cancer Association group to investigate cancer associated alterations (PRACTICAL) Consortium. |
| first_indexed | 2024-03-06T21:22:23Z |
| format | Journal article |
| id | oxford-uuid:41e5711a-8647-4ba6-a912-dafe3d234227 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:22:23Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:41e5711a-8647-4ba6-a912-dafe3d2342272022-03-26T14:46:20ZCommon variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:41e5711a-8647-4ba6-a912-dafe3d234227EnglishSymplectic Elements at Oxford2013Lose, FBatra, JO'Mara, TFahey, PMarquart, LEeles, REaston, DAl Olama, AKote-Jarai, ZGuy, MMuir, KLophatananon, ARahman, ANeal, DHamdy, FDonovan, JChambers, SGardiner, RAitken, JYaxley, JAlexander, KClements, JSpurdle, ABKedda, MThe human tissue Kallikrein family consists of 15 genes with the majority shown to be differentially expressed in cancers and/or indicators of cancer prognosis. We sought to elucidate the role of common genetic variation in four of the Kallikrein genes, KLK5, KLK6, KLK12, and KLK13, in prostate cancer risk and tumor aggressiveness. Genotyping of all 22 tagging single nucleotide polymorphisms (tagSNPs) in the KLK5, KLK6, KLK12, and KLK13 genes was performed in approximately 1,000 prostate cancer cases and 1,300 male controls from Australia. Data from any positive results were also accessed for 1,844 cases and 1,886 controls from a previously published prostate cancer genome-wide association study set from the United Kingdom. For one SNP in KLK12, rs3865443, there was evidence for association with prostate cancer risk of similar direction and magnitude in the replication set to that seen in the Australian cohort. We conducted genotyping of a further 309 prostate cancer cases, and combined analyses revealed an increased risk of prostate cancer for carriers of the rare homozygous genotype for rs3865443 (OR 1.28, 95% CI 1.04-1.57; P = 0.018). No other tagSNPs in the KLK5, KLK6, and KLK13 genes were consistently associated with prostate cancer risk or tumor aggressiveness. Analysis of a combined sample of 3,153 cases and 3,199 controls revealed the KLK12 tagSNP rs3865443 to be marginally statistically significantly associated with risk of prostate cancer. Considering the total number of SNPs investigated in this study, this finding should be interpreted cautiously and requires additional validation from very large datasets such as those of the Prostate Cancer Association group to investigate cancer associated alterations (PRACTICAL) Consortium. |
| spellingShingle | Lose, F Batra, J O'Mara, T Fahey, P Marquart, L Eeles, R Easton, D Al Olama, A Kote-Jarai, Z Guy, M Muir, K Lophatananon, A Rahman, A Neal, D Hamdy, F Donovan, J Chambers, S Gardiner, R Aitken, J Yaxley, J Alexander, K Clements, J Spurdle, AB Kedda, M Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title | Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title_full | Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title_fullStr | Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title_full_unstemmed | Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title_short | Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. |
| title_sort | common variation in kallikrein genes klk5 klk6 klk12 and klk13 and risk of prostate cancer and tumor aggressiveness |
| work_keys_str_mv | AT losef commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT batraj commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT omarat commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT faheyp commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT marquartl commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT eelesr commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT eastond commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT alolamaa commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT kotejaraiz commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT guym commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT muirk commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT lophatananona commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT rahmana commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT neald commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT hamdyf commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT donovanj commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT chamberss commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT gardinerr commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT aitkenj commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT yaxleyj commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT alexanderk commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT clementsj commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT spurdleab commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness AT keddam commonvariationinkallikreingenesklk5klk6klk12andklk13andriskofprostatecancerandtumoraggressiveness |